Chikungunya vaccine candidate fast tracked
by Press Release from Outbreak News Today on (#4A04C)
Themis Bioscience, a biopharmaceutical company focused on immunomodulation therapies for infectious diseases and cancer, announced today that the United States Food and Drug Administration (FDA) has granted fast track designation to the Company's lead vaccine candidate (MV-CHIK) for the prevention of Chikungunya, a debilitating disease with global outbreak potential. The program is the most advanced ["]
The post Chikungunya vaccine candidate fast tracked appeared first on Outbreak News Today.